OTC · Medical - Pharmaceuticals

Core One Labs Inc. (CLABF) Stock

$0.00 OTC: CLABF Healthcare

Core One Labs Inc. operates as a psychedelic research and development company.

Valuation

MetricValue
Price$0.00
Market Cap$471
P/E Ratio-0.28
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.04
52-Week High$0.03
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-228.57%
ROA-200.00%
ROCE-116.71%
Gross Margin100.00%
Operating Margin-452.37%
Net Margin0.00%
Debt/Equity0.04
Current Ratio0.81

Annual Financials (USD)

Metric20182019202020212022
Revenue$4.0M$5.0M$0$0$0
Operating Profit$-12.0M$-15.0M$-7.0M$-12.0M$-8.0M
Net Profit$-12.0M$-21.0M$-55.0M$-37.0M$-16.0M
EPS$-10.56$-15.25$-10.27$-2.57$-0.49
Op Margin-292.1%-304.2%—-2820.5%-1709.2%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$21.0M$18.0M$10.0M$8.0M$8.0M
Total Liabilities$5.0M$12.0M$4.0M$3.0M$1.0M
Cash$0$0$1.0M$1.0M$1.0M
Borrowings$1.0M$4.0M$0$0$0

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-10.0M$-6.0M$-2.0M$-5.0M$-3.0M
Investing Cash Flow$-13.0M$-1.0M$0$1.0M$0
Financing Cash Flow$14.0M$1.0M$0$0$0
Net Cash Flow$-2.0M$0$0$0$0
Free Cash Flow$-17.0M$-7.0M$-2.0M$-5.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.41
FCF Yield-29.42%
Quick Ratio0.81
Interest Coverage-1427.05
Return 1Y-99.95%
Return 3Y-100.00%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Main Street Group, Ltd 1252026-06-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CNGGFCann Group Limited $0.00 — 0.27 $2.40M 0.00%
CTABFCanntab Therapeutics Limited $0.00 — 0.00 $3891 0.00%
DOSEFDoseology Sciences Inc. $0.11 +0.00% -1.32 $501357 0.00%
ENZNViskase Companies, Inc. $4.71 +1.29% -0.91 $31.14M 0.00%
FNAMEvolutionary Genomics, Inc. $0.00 — 0.00 $1331 0.00%

About Core One Labs Inc.

Core One Labs Inc. operates as a psychedelic research and development company. The company focuses on providing psychedelic medicines to novel delivery systems and psychedelic assisted psychotherapy; and intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. It also provides natural health products; news dissemination services; financing services; and operates medical clinics, as well as engages in micro cultivation. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

Core One Labs Inc. (CLABF) stock trades at $0.00 with a market capitalization of $471. The stock is valued at a price-to-earnings (P/E) ratio of -0.28, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.03, and currently trades 100.0% below its 52-week high.

On profitability, Core One Labs Inc. generates a return on equity (ROE) of -228.57%, return on capital employed of -116.71%, an operating margin of -452.37%, a net profit margin of 0.00%.

Official website: core1labs.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides